You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Drug Price Trends for HEAD CONGESTION-MUCUS CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HEAD CONGESTION-MUCUS CAPLET

Average Pharmacy Cost for HEAD CONGESTION-MUCUS CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11597 EACH 2024-12-18
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11453 EACH 2024-11-20
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11741 EACH 2024-10-23
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11283 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Head Congestion-Mucus Caplets

Introduction

Head congestion and mucus relief caplets are a staple in the over-the-counter (OTC) pharmaceutical market, providing essential relief for symptoms associated with the common cold, allergies, and other respiratory issues. This analysis will delve into the market dynamics, consumer demand, and price projections for these caplets.

Market Size and Growth

The market for expectorant drugs, which includes head congestion and mucus relief caplets, is substantial and growing. As of 2023, the global expectorant drugs market was valued at $16,384.6 million, with a growth rate of 5% from 2019 to 2023[3].

For 2024, the expectorant drugs market is projected to reach $17,648.2 million, and by 2034, it is expected to grow to $38,455.4 million, representing a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period[3].

Consumer Demand

Consumer demand for head congestion and mucus relief caplets is driven by several factors:

  • Respiratory Health: The emphasis on maintaining good respiratory health, especially post-pandemics like COVID-19, has increased the demand for these products[3].
  • Seasonal Variations: Demand peaks during cold and flu seasons, making these products a necessity for many consumers.
  • Non-Drowsy Formulas: Products like SUDAFED PE® Head Congestion & Mucus Relief Medicine, which are non-drowsy, appeal to a wide range of consumers who need relief without the side effect of drowsiness[1][2].

Product Variations and Active Ingredients

The market offers various formulations to cater to different needs:

  • SUDAFED PE® Head Congestion & Mucus Relief Medicine: Contains acetaminophen, guaifenesin, and phenylephrine HCl, providing relief from sinus pain, pressure, headache, congestion, and excess mucus[1].
  • SUDAFED PE® Head Congestion + Pain Relief: Combines ibuprofen and phenylephrine HCl for pain relief and decongestant properties[2].
  • SUDAFED® Sinus Congestion Relief: Uses pseudoephedrine HCl for maximum strength decongestant relief[4].

Price Projections

The pricing of head congestion and mucus relief caplets can vary based on the brand, formulation, and market conditions.

  • Current Pricing: Products like TopCare Head Congestion + Mucus PE caplets are priced around $7.49 for a 24-count package, indicating a competitive pricing strategy[5].
  • Future Pricing Trends: Given the projected growth in the expectorant drugs market, prices may remain stable or see a slight increase due to increased demand and potential supply chain costs. However, competition among brands is likely to keep prices competitive.

Competitive Landscape

The market is highly competitive, with several brands vying for market share:

  • SUDAFED: A leading brand recommended by pharmacists, offering various formulations to address different symptoms[1][2][4].
  • TopCare: A store brand offering similar formulations at competitive prices[5].
  • Generic and Store Brands: Other generic and store brands also compete in this space, offering affordable alternatives.

Regulatory Considerations

Recent regulatory changes could impact the market:

  • FDA Proposed Order: The FDA has proposed removing oral phenylephrine from the OTC monograph, which could affect the formulation of some products. However, this is not related to safety concerns[1][2].

Consumer Preferences and Trends

Consumers are increasingly looking for products that are effective, safe, and convenient:

  • Non-Drowsy Formulas: There is a strong preference for non-drowsy formulas to ensure that daily activities are not disrupted.
  • Multi-Symptom Relief: Products that offer relief from multiple symptoms, such as headache, fever, and congestion, are highly sought after.
  • Natural and Organic Options: Some consumers are shifting towards natural and organic alternatives, although traditional OTC products remain dominant.

Key Takeaways

  • The expectorant drugs market, including head congestion and mucus relief caplets, is expected to grow significantly by 2034.
  • Consumer demand is driven by the need for effective, non-drowsy relief from respiratory symptoms.
  • Pricing is competitive, with brands offering various formulations at different price points.
  • Regulatory changes may influence product formulations but are not expected to impact safety.

FAQs

Q: What are the active ingredients in SUDAFED PE® Head Congestion & Mucus Relief Medicine? A: The active ingredients include acetaminophen (325 mg), guaifenesin (200 mg), and phenylephrine HCl (5 mg)[1].

Q: Why is the FDA proposing to remove oral phenylephrine from the OTC monograph? A: The FDA proposed order is not related to safety concerns but rather a regulatory review of the OTC monograph[1][2].

Q: What is the projected market value of the expectorant drugs market by 2034? A: The expectorant drugs market is expected to reach $38,455.4 million by 2034[3].

Q: Are there any specific consumer preferences in the market for head congestion and mucus relief caplets? A: Consumers prefer non-drowsy formulas and products that offer relief from multiple symptoms[1][2].

Q: How does the competitive landscape affect pricing in this market? A: The competitive landscape keeps prices competitive, with various brands offering similar products at different price points[5].

Sources

  1. SUDAFED PE® Head Congestion & Mucus Relief Medicine - SUDAFED
  2. SUDAFED PE® Head Congestion + Pain Relief Decongestant Caplets - SUDAFED
  3. Global Expectorant Drugs Market Growth Projection 2024-2034 - Future Market Insights
  4. SUDAFED® Sinus Congestion Relief Decongestant with Pseudoephedrine HCl - SUDAFED
  5. TopCare Head Congestion + Mucus PE, Non-Drowsy, Caplets - Save Mart

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.